The value of "first impression" moments Interestingly, starting a GLP-1 didn't appear to help women who already had jobs earn more or work more hours
The CV benefits of semaglutide in these people with overweight or obesity who have preexisting CVD are due to pleiotropic factors other than weight or glucose-lowering effects, Lingvay said
In absolute terms, participants receiving semaglutide lost 15.3 kg compared with 2.6 kg in the placebo group
During the holidays, BMI is helpful for one reason: it reminds you that this journey is about health trends over timenot what the scale does between December 20 and January 2
Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J et al (2025) Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Tirzepatide is a sophisticated medication known as a dual-receptor agonist